Search research articles
Contact Us
Filters
Showing results (1-10 of 112) with videos related to
Page
of 12
Sort By:
Blood
|
October 30, 2016
MISTRG extends PDX modeling to favorable AMLs
Mark Wunderlich, James C Mulloy
Oncogene
|
June 25, 2002
Mdm2 inhibition of p53 induces E2F1 transactivation via p21
Mark Wunderlich, Steven J Berberich
Methods in Molecular Biology (Clifton, N.J.)
|
March 12, 2009
Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transduction
Mark Wunderlich, James C Mulloy
Blood
|
March 13, 2015
Xenograft models for normal and malignant stem cells
Susumu Goyama, Mark Wunderlich, James C Mulloy
Cell Cycle (Georgetown, Tex.)
|
October 25, 2008
Transforming human blood stem and progenitor cells: a new way forward in leukemia modeling
James C Mulloy, Mark Wunderlich, Yi Zheng, et al.
Blood
|
May 4, 2006
Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability
Mark Wunderlich, Ondrej Krejci, Junping Wei, et al.
Cell Cycle (Georgetown, Tex.)
|
January 24, 2004
MdmX represses E2F1 transactivation
Mark Wunderlich, Mithua Ghosh, Karen Weghorst, et al.
Blood
|
January 5, 2011
N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene
Fu-Sheng Chou, Mark Wunderlich, Andrea Griesinger, et al.
Oncotarget
|
August 11, 2016
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation
Shan Lin, Junping Wei, Mark Wunderlich, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
June 14, 2002
Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model
Christian Schlensak, Torsten Doenst, Stefan Preusser, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 112) with videos related to
Sort By:
Page
of 12
Blood
|
October 30, 2016
MISTRG extends PDX modeling to favorable AMLs
Mark Wunderlich, James C Mulloy
Oncogene
|
June 25, 2002
Mdm2 inhibition of p53 induces E2F1 transactivation via p21
Mark Wunderlich, Steven J Berberich
Methods in Molecular Biology (Clifton, N.J.)
|
March 12, 2009
Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transduction
Mark Wunderlich, James C Mulloy
Blood
|
March 13, 2015
Xenograft models for normal and malignant stem cells
Susumu Goyama, Mark Wunderlich, James C Mulloy
Cell Cycle (Georgetown, Tex.)
|
October 25, 2008
Transforming human blood stem and progenitor cells: a new way forward in leukemia modeling
James C Mulloy, Mark Wunderlich, Yi Zheng, et al.
Blood
|
May 4, 2006
Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability
Mark Wunderlich, Ondrej Krejci, Junping Wei, et al.
Cell Cycle (Georgetown, Tex.)
|
January 24, 2004
MdmX represses E2F1 transactivation
Mark Wunderlich, Mithua Ghosh, Karen Weghorst, et al.
Blood
|
January 5, 2011
N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene
Fu-Sheng Chou, Mark Wunderlich, Andrea Griesinger, et al.
Oncotarget
|
August 11, 2016
Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation
Shan Lin, Junping Wei, Mark Wunderlich, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
June 14, 2002
Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model
Christian Schlensak, Torsten Doenst, Stefan Preusser, et al.
Page
of 12